Determination of time in range associated with HbA1c <= 6.5% in Latin American pregnant women diagnosed with type 1 diabetes mellitus using an automated insulin delivery system

dc.catalogadorjwg
dc.contributor.authorMedina, Ana Maria Gomez
dc.contributor.authorChavez, Maria Juliana Soto
dc.contributor.authorCarrillo, Diana Cristina Henao
dc.contributor.authorSanchez, Juan Camilo Salgado
dc.contributor.authorGonzalez, Javier Alberto Gomez
dc.contributor.authorGrassi Corrales, Bruno
dc.contributor.authorVelandia, Oscar Mauricio Munoz
dc.date.accessioned2024-05-30T15:28:14Z
dc.date.available2024-05-30T15:28:14Z
dc.date.issued2023
dc.description.abstractAims: To determine the correlation between %TIR and HbA1c in pregnant women with type 1 diabetes mellitus (DM1)., Methods: Diagnostic test study in a prospective cohort of pregnant patients with DM1 using automated insulin delivery system (AID) in Colombia and Chile., Results: Fifty-two patients were included [mean age 31.8 +/- 6.2 years, pregestational HbA1c 7.2% [interquartile range (IQR), 6.5-8.2]. During follow-up, we found a better metabolic control during the second (HbA1c 6.40%, IQR 5.9,7.1) and third trimesters (HbA1c 6.25%;IQR 5.9,6.8). A weak and negative correlation between %TIR and HbA1c was found for all the gestation (Spearman's rank correlation coefficient:-0.22, p:0.0329), and in the second (r:-0.13, p: 0.38) and third trimesters (r:-0.26, p = 0.08). %TIR had poor discriminating capacity for predicting HbA1c < 6% (area under the curve [AUC], 0.59; 95% confidence interval [CI],0.46-0.72) and for predicting HbA1c < 6.5% (AUC, 0.57;95% CI,0.44-0.70). The optimal cutoff points for %TIR were > 66.1% for predicting HbA1c < 6% (65% sensitivity, 62% specificity) and %TIR > 61.1% for HbA1c < 6.5% (59% sensitivity, 54% specificity)., Conclusion: The correlation between HbA1c and %TIR during pregnancy was weak. The optimal cutoff points for identifying patients with HbA1c < 6.0% and < 6.5% were %TIR > 66.1% and > 61.1%, respectively, with moderate sensitivity and specificity.
dc.fechaingreso.objetodigital2024-10-18
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.diabres.2023.110713
dc.identifier.eissn1872-8227
dc.identifier.issn0168-8227
dc.identifier.urihttps://doi.org/10.1016/j.diabres.2023.110713
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/85987
dc.identifier.wosidWOS:001001985400001
dc.information.autorucEscuela de Medicina; Grassi Corrales Bruno; 0000-0003-0095-9740; 132804
dc.language.isoen
dc.nota.accesoContenido parcial
dc.publisherELSEVIER IRELAND LTD
dc.revistaDIABETES RESEARCH AND CLINICAL PRACTICE
dc.rightsacceso restringido
dc.subjectTime in range
dc.subjectContinuous glucose monitoring
dc.subjectGlycated hemoglobin A1c
dc.subjectType 1 diabetes
dc.subjectPregnancy
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.titleDetermination of time in range associated with HbA1c <= 6.5% in Latin American pregnant women diagnosed with type 1 diabetes mellitus using an automated insulin delivery system
dc.typeartículo
dc.volumen200
sipa.codpersvinculados132804
sipa.trazabilidadORCID;2024-05-27
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Determination of time in range associated with HbA1c ≤ 6.5% in Latin American pregnant women diagnosed with type 1 diabetes mellitus using an automated insulin delivery system.pdf
Size:
3.26 KB
Format:
Adobe Portable Document Format
Description: